RE:RE:RE:Shorts...We no longer need a Pierre interview on what is coming. This will probably only drive the share price lower, sad as this is to say. What we need, and nothing short of this, is an FDA licence for Ryplasim. A pediatric voucher represents the kind of news the bashers can't rationalize away, so we need that also.
Good luck,
Felco